SLAIY SOLAI Ltd Annual reports only
Finance Services · OTC · SEC CIK 1517496
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $23.00M | $32.92M | $43.10M | $57.02M | $53.77M |
| Cost of revenue | $23.72M | $18.58M | $29.11M | $35.02M | $24.78M |
| R&D expense | — | $69,000 | $874,000 | $2.21M | $1.26M |
| SG&A expense | $18.25M | $13.71M | $18.46M | $21.95M | $22.27M |
| Operating income | -$34.70M | -$8.01M | -$25.19M | -$89.64M | -$44.32M |
| Interest expense | — | — | — | $218,000 | $775,000 |
| Pretax income | -$34.48M | -$7.01M | -$25.38M | -$79.42M | -$39.89M |
| Income tax | $0 | $0 | $0 | $0 | -$359,000 |
| Net income | -$33.88M | $12.07M | -$28.71M | -$155.41M | -$62.40M |
| EBITDA | -$22.39M | $2.14M | -$15.34M | -$65.59M | -$29.26M |
| EPS (basic) | -0.02 | 0.01 | -0.03 | -0.18 | -0.10 |
| EPS (diluted) | -0.02 | 0.01 | -0.03 | -0.18 | -0.10 |
| Weighted avg. shares (diluted) | 1.73B | 1.17B | 1.10B | 871.04M | 622.34M |
| Balance sheet | |||||
| Cash & equivalents | $1.42M | $1.81M | $3.24M | $5.57M | $17.80M |
| Short-term investments | $0 | $0 | $0 | $2.36M | — |
| Receivables | $2.76M | $1.84M | $2.88M | $3.58M | $737,000 |
| Current assets | $17.68M | $19.15M | $33.86M | $35.34M | $93.26M |
| PP&E, net | $12.17M | $19.90M | $22.83M | $27.21M | $70.20M |
| Goodwill | — | $0 | $0 | — | $26.57M |
| Intangibles | $5.86M | $11.08M | $2.03M | $3.30M | $71.93M |
| Total assets | $45.61M | $86.33M | $72.60M | $86.80M | $294.23M |
| Current liabilities | $10.02M | $11.24M | $44.93M | $30.84M | $84.40M |
| Total liabilities | $10.88M | $19.55M | $47.46M | $33.68M | $88.97M |
| Shareholders' equity | $34.23M | $56.89M | $25.13M | $53.13M | $179.89M |
| Cash flow statement | |||||
| Operating cash flow | -$26.93M | -$32.74M | -$28.41M | -$63.56M | -$34.27M |
| Capital expenditure | $220,000 | $1.18M | $1.43M | $13.78M | $56.60M |
| Free cash flow | -$27.15M | -$33.92M | -$29.84M | -$77.34M | -$90.87M |
| Investing cash flow | $15.91M | $28.85M | $26.16M | $24.39M | -$75.41M |
| Financing cash flow | $10.69M | $2.37M | — | $29.77M | $77.67M |
| Depreciation & amortization | $12.31M | $10.15M | $9.86M | $24.05M | $15.06M |
| Stock-based compensation | $851,000 | $1.21M | $1.03M | $4.47M | $6.45M |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.